ARCHIVES

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Nobelist Offer “Electronic” Theory Of Cancer

June 27, 1975

FDA Committee Approves Two NDAs, Blocks One, Hears NCI Toxicology Plan

June 15, 1979

Frist Backs Federal Funding For Stem Cell Research.

July 20, 2001

In Brief: Balch, Morton Head SSO; Schantz, Rosen Move To MSK; Old Directs US Branch Of Ludwig Inst.

May 10, 1991

In Brief: NCI’s “Constant Dollar” Budget For FY 1979 Equal To 1975 Amount; Decosse Move to S-K

September 22, 1978

NCI Division To Promote Funds To Promote Collaboration.

February 18, 2000